🚭 Follow‑up Analysis: From “Tobacco Advertising” ➡️ “All Nicotine Promotion”

Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single regulatory category. The emphasis is shifting from differentiated risk communication to a comprehensive, product‑agnostic ban on advertising, promotion, and sponsorship. 📑 Key Shifts in Policy…

🚭 GINN Initial Analysis: Commission’s TPD Evaluation Overstates Success, Undermines Harm Reduction

The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products. 🔍 Framing & Methodology • Smoking prevalence reduction is treated as the main success metric, yet the evaluation does not convincingly isolate the TPD’s impact…

GINN Insight: Brazil and New Zealand: Policy Pathways and Smoking Outcomes

Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New Zealand highlights how differing policy approaches toward nicotine products are associated with divergent trends in smoking prevalence. Both countries have implemented strong tobacco control measures…

GINN Insight: Ireland’s EU Presidency: Public Health, Prevention, and Policy Coordination

Ireland’s upcoming Presidency of the Council of the European Union presents a strategic opportunity to shape Europe’s public health agenda at a time of growing pressure on health systems and widening inequalities in outcomes. Recent discussions highlight a clear direction: stronger coordination, a renewed focus on prevention, and the need to address high-burden diseases through…

This Does Not Need to Be a Shouting Match

Debates on tobacco and nicotine policy within the European Union have often been characterised by strong views and high levels of engagement. This reflects the importance of the issue. Tobacco use remains a leading cause of preventable disease, and decisions taken by policymakers have long-term implications for public health across Member States. However, the intensity…

Rules and Taxes Need to Pull in the Same Direction

European tobacco and nicotine policy is shaped by several regulatory instruments. Among the most important are the Tobacco Products Directive (TPD), which establishes product standards and regulatory requirements, and the Tobacco Excise Directive (TED), which governs how tobacco products are taxed across the European Union. Although these two frameworks address different aspects of regulation, their…

Tax Policy Shapes Choices

The revision of the European Union’s Tobacco Excise Directive (TED) presents an important moment for policymakers to reconsider how taxation influences tobacco and nicotine use across Member States. While excise policy is often described as a technical fiscal instrument, its impact extends far beyond government revenue. Tax policy directly shapes consumer behaviour, market dynamics, and…

Risk-Proportionate Taxation and the Public Health Role of Nicotine Pouches

Excise taxation is one of the most powerful tools in tobacco control. Price signals influence initiation, continuation, cessation, and product switching. As nicotine markets diversify beyond combustible cigarettes, the question facing policymakers is no longer simply whether to tax nicotine products, but how to structure taxation in a way that aligns with relative risk and…